The proposed approach consists of three stages: (i) eliminate the frequency split between a pair of predominantly in-plane modes and a pair of predominantly out-of-plane modes; (ii) eliminate the cross-coupling between the in-plane and out-of-plane modes; (iii) match the in-plane and out-of-plane natural frequencies.
There were five siRNA families complementarily matching to the long npcRNAs, among which, three groups (group I, group II, group III) matched both TalnRNA9 and TalnRNA12, and other two (group IV group V) were specific for TalnRNA9 (Additional file 6).
ii) Addressing skills in the CCC sectors within the Learning Programme (below) iii) Matching RO and CO technical capacity to the CCCs by ensuring that each sector is supported by an Advisor or Programme Officer with relevant skills/experience.
Figure 1A and B show the cumulative survival rates in the patients with and without cirrhosis in the APACHE III-matched and SOFA-matched groups, respectively.
In both the APACHE III-matched and SOFA-matched groups, the cumulative survival rates significantly differed when an underlying AKI was considered.
In the APACHE III-matched group, the SOFA scoring system demonstrated the highest prediction ability (AUROC = 0.810 ± 0.056) among all 3 systems.
In the APACHE III-matched group, the SOFA scoring system had the best Youden's index among the patients with cirrhosis, whereas the APACHE III scoring system had the best Youden's index among the total population.
The patients with cirrhosis in the SOFA-matched group showed higher GCS and lower SCr concentrations on Day 1 of ICU admission, whereas these differences were nonsignificant in the APACHE III-matched group.
As shown in Table 4, in the APACHE III-matched group, the SOFA score demonstrated a higher discrimination ability in the patients with cirrhosis than in the patients without cirrhosis (AUROC = 0.810 ± 0.056 vs 0.624 ± 0.060).
In the APACHE III-matched group, the SOFA scores of patients with cirrhosis were significantly higher than those of patients without cirrhosis (P < .001), whereas the difference in APACHE III scores was nonsignificant between the SOFA-matched patients with and without cirrhosis.
